Wen-Hann Tan

Course Director, Advanced Human Genetics Course · Boston Childrens Hospital

Credentials: · · ·

History

2024 ASXL-Related Disorders Scientific Conference and Family Meeting
National Institute of Child Health and Human Development · R13
PI · $30.4K · University of California Los Angeles
2024–2025
ASXL-Related Disorders Scientific Conference and Family Meeting
National Institute of Child Health and Human Development · R13
PI · $15K · University of California Los Angeles
2021–2022
A Prospective Natural History Study of Angelman Syndrome: A Fresh Approach to a 10-Year Longitudinal Study to Facilitate Development of Novel Therapeutic Products
Food and Drug Administration · R01
Contact PI · $2M · Boston Children's Hospital
2017–2022
A Phase II Trial of Levodopa in Angelman Syndrome
Food and Drug Administration · R01
Contact PI · $1.5M · Boston Children's Hospital
2010–2016

ASXL-Related Disorders Natural History Study
Principal investigator · Recruiting
University of California, Los Angeles
2017–2037
A Trial of Levodopa in Angelman Syndrome
Principal investigator · Completed · Phase 2, Phase 3
Wen-Hann Tan
2011–2015
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Principal investigator · Completed · Phase 1
Boston Children's Hospital
2009–2010
Dietary Supplements for the Treatment of Angelman Syndrome
Principal investigator · Completed
University of California, San Diego
2006–2010